A silhouette of a person running along a serene lakeshore at sunset, symbolizing determination, progress, and hope for a healthier future.A silhouette of a person running along a serene lakeshore at sunset, symbolizing determination, progress, and hope for a healthier future.

Together we can.

We strive to listen and learn from patients, families, and advocacy groups to understand daily challenges and how our medicines can help patients live their best lives.

Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP)

EPP and XLP are rare genetic disorders that affect the body's ability to produce heme leading to an excessive buildup of protoporphyrin IX (PPIX), a heme intermediate. PPIX is highly toxic and photoreactive causing liver damage and severe, painful skin reactions upon exposure to sunlight.



With no approved disease-modifying treatments, patients take extreme measures to avoid sunlight. Upon sunlight exposure, patients may experience disabling pain attacks that can last for days and cause chronic skin lesions and scarring. Additionally, many patients experience liver disease, with severe cases requiring transplantation.
A joyful moment of a father carrying his child on his shoulders at the beach, symbolizing hope and resilience for families impacted by EPP and XLP.

Keep informed about upcoming clinical trials.

Receive updates on upcoming clinical trials and opportunities to contribute to life-changing advancements.
You may opt out any time. Privacy Policy
Thank you for your interest. We will process this as soon as possible.